Proximagen Company
Proximagen is a neuroscience research company developing drugs for neurodegenerative disorders, including Parkinson’s and Alzheimers.
Founded Date:
2003
Total Funding:
$96.5M
Investor Type:
Company
Employee Number:
11-50
Investment Stage:
N/A
Funding Status:
N/A
Number Of Exists:
Venture - Series Unknown
Technology:
Others
Last Funding Type:
Venture - Series Unknown
Investors Number:
1
Industry:
PharmTech
Headquarters:
London, England, United Kingdom
Estimated Revenue:
$1M to $10M